The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.


pill on ECG.

Patients with atrial fibrillation or Afib have a five-fold increased risk of stroke, mostly caused by blood clots. In order to lower the risk of blood clots, physicians often prescribe blood thinners such as aspirin and clopidogrel (Plavix) and anticoagulants such as warfarin (Coumadin), rivaroxaban (Xarelto), and dabigatran (Pradaxa). Anticoagulants can also be used to control heart rate and heart rhythm.

Controlling Heart Rate

If the goal of pharmacological therapy is to slow down a rapid heart rate, beta-blockers and calcium channel blockers are typically used. Examples of beta blockers include propranolol (Inderal), atenolol (Tenormin), metoprolol (Lopressor), and esmolol (Brevibloc). Examples of calcium channel blockers include verapamil (Calan) and diliazem (Cardizem). These medications slow the heart rate by slowing the rate of electrical conduction throughout the heart, but they typically do not cause the heart to beat with a normal rhythm.

Controlling Heart Rhythm

Rather than control the patient’s heart rate, a physician may decide that controlling the patient’s heart rhythm is more appropriate. An approach aimed at converting Afib to a normal heart rhythm (also known as normal sinus rhythm) is more likely to be utilized in younger patients, patients whose heart chambers are not enlarged, and patients with paroxysmal atrial fibrillation. In these instances, antiarrhythmic drugs are used. The most commonly prescribed antiarrhythmic agents include quinidine, propafenone, dofetilide, sotalol (Betapace), flecainide (Tambocor) and amiodarone (Cordarone).

Medications used to treat Afib are not without side effects, and in some cases require periodic monitoring. For example, patients taking warfarin must have their blood tested on a regular basis, usually once or twice a month. Side effects for other commonly prescribed drugs include:

  • Beta-blockers: fatigue, low blood pressure, and coldness of hands and feet
  • Verapamil: low blood pressure, ankle swelling, and heart failure
  • Flecainide: nausea, vomiting and heart rhythm disorders
  • Amiodarone: sensitivity to sunlight, changes to liver or thyroid function and lung problems

Sources: American Heart Association, The National Blood Clot Alliance (NBCA)